002603 以岭药业
已收盘 04-30 15:00:00
资讯
新帖
简况
以岭药业获信达证券增持评级,推动新药研发
金融界 · 04-30
以岭药业获信达证券增持评级,推动新药研发
以岭药业非呼吸系统类产品营收创历史新高 中医药临床循证研究筑牢科技核心竞争力
新浪证券 · 04-29
以岭药业非呼吸系统类产品营收创历史新高 中医药临床循证研究筑牢科技核心竞争力
以岭药业:4月28日召开业绩说明会,华创证券、华福证券等多家机构参与
证券之星 · 04-28
以岭药业:4月28日召开业绩说明会,华创证券、华福证券等多家机构参与
图解以岭药业一季报:第一季度单季净利润同比减74.73%
证券之星 · 04-27
图解以岭药业一季报:第一季度单季净利润同比减74.73%
以岭药业(002603.SZ)发一季度业绩,净利润3.04亿元,同比减少74.73%
智通财经网 · 04-26
以岭药业(002603.SZ)发一季度业绩,净利润3.04亿元,同比减少74.73%
以岭药业(002603.SZ)发2023年度业绩,净利润13.52亿元,同比减少42.76%
智通财经 · 04-26
以岭药业(002603.SZ)发2023年度业绩,净利润13.52亿元,同比减少42.76%
年报出炉|以岭药业2023年研发投入9.35亿,占营收9%
证券之星 · 04-26
年报出炉|以岭药业2023年研发投入9.35亿,占营收9%
暴雪、冻雨、强对流天气来袭,这些企业是否有影响?
第一财经 · 02-21
暴雪、冻雨、强对流天气来袭,这些企业是否有影响?
两大龙头发布股权激励方案!中药板块应声走强,机构:关注行业的增量变化
格隆汇 · 01-03
两大龙头发布股权激励方案!中药板块应声走强,机构:关注行业的增量变化
以岭药业董秘吴瑞:预祝2024年身体健康,万事如意,阖家幸福
新浪证券 · 2023-12-29
以岭药业董秘吴瑞:预祝2024年身体健康,万事如意,阖家幸福
以岭药业董秘吴瑞:中药研发创新是独具特色的 希望研发出更多好药造福大众
新浪证券 · 2023-12-22
以岭药业董秘吴瑞:中药研发创新是独具特色的 希望研发出更多好药造福大众
A股异动 | 流感念股以岭药业连涨3日 “辛芪通鼻片”新药注册申请获受理
港股那点事 · 2023-11-27
A股异动 | 流感念股以岭药业连涨3日 “辛芪通鼻片”新药注册申请获受理
以岭药业(002603.SZ):辛芪通鼻片新药注册申请获受理
智通财经网 · 2023-11-23
以岭药业(002603.SZ):辛芪通鼻片新药注册申请获受理
三大指数震荡走高,汽车板块上演“王者归来”!
财华社 · 2023-11-23
三大指数震荡走高,汽车板块上演“王者归来”!
以岭药业(002603.SZ):连花清咳片处方药转换为非处方药获得批准
智通财经网 · 2023-11-22
以岭药业(002603.SZ):连花清咳片处方药转换为非处方药获得批准
中医药研究首登医学顶刊!以岭药业增长潜力凸显
新浪证券 · 2023-11-22
中医药研究首登医学顶刊!以岭药业增长潜力凸显
加载更多
公司概况
公司名称:
石家庄以岭药业股份有限公司
所属行业:
医药制造业
上市日期:
2011-07-28
主营业务:
石家庄以岭药业股份有限公司是一家主要致力于专利创新中药的研发、生产和销售。公司拥有通过GMP认证的胶囊、片剂、颗粒剂、针剂生产线,以及通过欧盟认证的化学药制剂车间。
发行价格:
34.56
{"stockData":{"symbol":"002603","market":"SZ","secType":"STK","nameCN":"以岭药业","latestPrice":18.83,"timestamp":1714460637000,"preClose":19.05,"halted":0,"volume":17036715,"delay":0,"floatShares":1377000000,"shares":1671000000,"eps":0.2717,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.22,"latestTime":"04-30 15:00:00","open":19,"high":19.06,"low":18.7,"amount":321000000,"amplitude":0.0189,"askPrice":18.83,"askSize":814,"bidPrice":18.82,"bidSize":967,"shortable":0,"etf":0,"ttmEps":0.2717,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":19.05,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":20.96,"lowLimit":17.15,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1670705376,"pbRate":2.71,"roa":"--","roe":"2.62%","epsLYR":0.8095,"committee":0.357641,"marketValue":31459000000,"floatMarketCap":25925000000,"peRate":69.304381,"changeRate":-0.0115,"turnoverRate":0.0124,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-05-06。"},"requestUrl":"/m/hq/s/002603/","defaultTab":"news","newsList":[{"id":"2431393402","title":"以岭药业获信达证券增持评级,推动新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2431393402","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431393402?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:24","pubTimestamp":1714465466,"startTime":"0","endTime":"0","summary":"4月30日,以岭药业获信达证券增持评级,近一个月以岭药业获得2份研报关注。信达证券指出,以岭药业其他专利产品销售保持稳定增长,并且在心脑血管和健康产品研发领域取得进展。展望未来,信达证券看好以岭药业在中药、化生药两大核心板块新药研发所带来的业绩增长潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301624308b656d8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301624308b656d8a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431738042","title":"以岭药业非呼吸系统类产品营收创历史新高 中医药临床循证研究筑牢科技核心竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2431738042","media":"新浪证券","top":-1,"share":"https://www.laohu8.com/m/news/2431738042?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:53","pubTimestamp":1714355580,"startTime":"0","endTime":"0","summary":" 4月26日晚间,以岭药业发布2023年年报。年报显示,在2022年高基数以及呼吸系统用药市场需求回归正常区间的背景下,公司业绩出现回调但整体幅度较小,报告期内仍实现营业收入103.18亿元,牢牢站稳百亿营收大关,展示出了较强的业绩韧性。从更长的时间跨度来看,2023年营收额相较于疫情前2019年的全年营收58.25亿元增幅显著,公司已整体步入新的发展阶段。非呼吸系统类产品营收总额为70.13亿元,同样创下历史新高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/med/2024-04-29/doc-inatncei1566571.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/med/2024-04-29/doc-inatncei1566571.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430030771","title":"以岭药业:4月28日召开业绩说明会,华创证券、华福证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2430030771","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430030771?lang=zh_cn&edition=full","pubTime":"2024-04-28 18:56","pubTimestamp":1714301770,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年4月28日以岭药业发布公告称公司于2024年4月28日召开业绩说明会,华创证券、华福证券、招商证券、民生证券、东北证券、中泰证券、国投证券、浙商证券、平安证券、信达证券、中邮证券、国盛证券、山西证券、西部证券、投资机构、海通证券、华泰证券、建投证券、兴业证券、中信证券、华安证券、国海证券参与。以岭药业主营业务:专利创新中药的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800007488.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430845427","title":"图解以岭药业一季报:第一季度单季净利润同比减74.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430845427","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430845427?lang=zh_cn&edition=full","pubTime":"2024-04-27 02:09","pubTimestamp":1714154991,"startTime":"0","endTime":"0","summary":"证券之星消息,以岭药业2024年一季报显示,公司主营收入25.23亿元,同比下降35.89%;归母净利润3.04亿元,同比下降74.73%;扣非净利润2.92亿元,同比下降75.18%;负债率31.46%,投资收益381.46万元,财务费用843.57万元,毛利率51.48%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042700003756.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430274313","title":"以岭药业(002603.SZ)发一季度业绩,净利润3.04亿元,同比减少74.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430274313","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2430274313?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:05","pubTimestamp":1714136710,"startTime":"0","endTime":"0","summary":"智通财经APP讯,以岭药业(002603.SZ)发布2024年第一季度报告,营业收入25.23亿元,同比减少35.89%。归属于上市公司股东的净利润3.04亿元,同比减少74.73%。归属于上市公司股东的扣除非经常性损益的净利润2.92亿元,同比减少75.18%。基本每股收益0.1819元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1112334.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430127109","title":"以岭药业(002603.SZ)发2023年度业绩,净利润13.52亿元,同比减少42.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430127109","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430127109?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:02","pubTimestamp":1714136531,"startTime":"0","endTime":"0","summary":"智通财经APP讯,以岭药业(002603.SZ)发布2023年年度报告,营业收入103.18亿元,同比减少17.67%。归属于上市公司股东的净利润13.52亿元,同比减少42.76%。归属于上市公司股东的扣除非经常性损益的净利润12.64亿元,同比减少45.58%。基本每股收益0.8095元,向全体股东每10股派发现金红利3.00元(含税),送红股0股(含税),不以公积金转增股本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1112327.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430789492","title":"年报出炉|以岭药业2023年研发投入9.35亿,占营收9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430789492","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430789492?lang=zh_cn&edition=full","pubTime":"2024-04-26 19:28","pubTimestamp":1714130887,"startTime":"0","endTime":"0","summary":"4月26日晚,以岭药业发布2023年年报。年报显示,2023年以岭药业实现营业收入103.18亿元,研发投入9.35亿,占营收9%。以岭药业主导产品均为独家产品,组方独特,在多个疾病领域占有独特的学术地位和市场地位。2023年,以岭药业研发投入9.35亿,同比增长4.41%,保持了持续增长态势。经过30余年的发展,以岭药业之所以成为行业翘楚,与其上述八大优势密不可分。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024042600048745.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2413461734","title":"暴雪、冻雨、强对流天气来袭,这些企业是否有影响?","url":"https://stock-news.laohu8.com/highlight/detail?id=2413461734","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2413461734?lang=zh_cn&edition=full","pubTime":"2024-02-21 19:10","pubTimestamp":1708513800,"startTime":"0","endTime":"0","summary":"面对雨雪天气,相关产业尤其是上市公司是否会受到影响?第一财经记者今天进行了采访。 据央视新闻客户端消息,中央气象台2月21日10时继续发布暴雪黄色预警:预计2月21日14时至22日14时,山东东南部、河南南部、安徽中部、江苏中部、湖北大部、湖南北部、重庆东部和北部、四川东北部、西藏东部等地有大雪,其中,安徽中部、湖北南部和东部、湖南北部、西藏东部等地的部分地区有暴雪。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/2024-02-21/doc-inaiuyre3035073.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/2024-02-21/doc-inaiuyre3035073.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2400196658","title":"两大龙头发布股权激励方案!中药板块应声走强,机构:关注行业的增量变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2400196658","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2400196658?lang=zh_cn&edition=full","pubTime":"2024-01-03 10:34","pubTimestamp":1704249277,"startTime":"0","endTime":"0","summary":"高质量发展持续推进","market":"us","thumbnail":"https://img3.gelonghui.com/476ba-ad90087b-f84d-40d7-a572-b8233ff36a3d.jpg?guru_height=854&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/476ba-ad90087b-f84d-40d7-a572-b8233ff36a3d.jpg?guru_height=854&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/680165","is_publish_highlight":false,"gpt_icon":0},{"id":"2395771151","title":"以岭药业董秘吴瑞:预祝2024年身体健康,万事如意,阖家幸福","url":"https://stock-news.laohu8.com/highlight/detail?id=2395771151","media":"新浪证券","top":-1,"share":"https://www.laohu8.com/m/news/2395771151?lang=zh_cn&edition=full","pubTime":"2023-12-29 11:02","pubTimestamp":1703818920,"startTime":"0","endTime":"0","summary":"专题:券商基金资本市场大佬2024新年寄语:时来运转 春暖花开\n 炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 辞旧迎新,送走不平凡的2003年,即将迎来2024,资本市场知名人士纷纷送上新年祝福。\n 以岭药业董秘吴瑞表示,新浪财经的朋友们大家好,我是以岭药业董事会秘书吴瑞, 2024 年即将到来,在这里预祝大家在新的一年里身体健康,万事如意,阖家幸福。\n\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:石秀珍 SF183","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/roll/2023-12-29/doc-imzzrxma6413221.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2023-12-29/doc-imzzrxma6413221.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2393453806","title":"以岭药业董秘吴瑞:中药研发创新是独具特色的 希望研发出更多好药造福大众","url":"https://stock-news.laohu8.com/highlight/detail?id=2393453806","media":"新浪证券","top":-1,"share":"https://www.laohu8.com/m/news/2393453806?lang=zh_cn&edition=full","pubTime":"2023-12-22 10:45","pubTimestamp":1703213100,"startTime":"0","endTime":"0","summary":"专题:新浪财经2023医药与资本论坛12月21日在北京举行 刘纪鹏、尹烨、蔡磊、劳志明、林园、朱国广等齐聚。 以岭药业董事、董事会秘书吴瑞女士莅临发布中医药传承与创新的主题演讲时表示,中药的研发创新是具有独有特色的,必须以理论和临床相结合。 同时,吴瑞表示,希望在未来与中药行业及其他领域的同道一起,共同努力筛选出更多更好的药品,推向市场、造福大众。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/y/2023-12-22/doc-imzyvzqh3784626.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/y/2023-12-22/doc-imzyvzqh3784626.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2386979753","title":"A股异动 | 流感念股以岭药业连涨3日 “辛芪通鼻片”新药注册申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2386979753","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2386979753?lang=zh_cn&edition=full","pubTime":"2023-11-27 09:44","pubTimestamp":1701049440,"startTime":"0","endTime":"0","summary":"以岭药业(002603.SZ)连涨3日,现涨3.54%报26.89元,股价创近半年新高,总市值449.3亿元。以岭药业近日公告,公司全资子公司北京以岭收到国家药品监督管理局下发的《受理通知书》,由北京以岭提交的“辛芪通鼻片”新药注册申请已获正式受理。辛芪通鼻片是公司自主研制的1.1类中药创新药,其功能主治为:益气固表,健脾通窍。用于持续性变应性鼻炎肺脾两虚证,症见喷嚏、流涕、鼻塞、鼻痒,自汗,恶风,神疲乏力,少气懒言等,舌淡,苔白,脉浮或脉细弱。\n\n现在送您60元福利红包,直接提现不套路~~~快来参与活动吧!\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-11-27/doc-imzvziqw1522113.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-11-27/doc-imzvziqw1522113.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2385628552","title":"以岭药业(002603.SZ):辛芪通鼻片新药注册申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2385628552","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2385628552?lang=zh_cn&edition=full","pubTime":"2023-11-23 18:52","pubTimestamp":1700736720,"startTime":"0","endTime":"0","summary":"以岭药业(002603.SZ)公告,公司全资子公司北京以岭药业有限公司(简称“北京以岭”)收到国家药品监督管理局下发的《受理通知书》,由北京以岭提交的“辛芪通鼻片”新药注册申请已获正式受理。公告显示,辛芪通鼻片是公司自主研制的1.1类中药创新药,其功能主治为:益气固表,健脾通窍。用于持续性变应性鼻炎肺脾两虚证,症见喷嚏、流涕、鼻塞、鼻痒,自汗,恶风,神疲乏力,少气懒言等,舌淡,苔白,脉浮或脉细弱。\n\n现在送您60元福利红包,直接提现不套路~~~快来参与活动吧!\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-23/doc-imzvrekk6164622.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-23/doc-imzvrekk6164622.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2385645643","title":"三大指数震荡走高,汽车板块上演“王者归来”!","url":"https://stock-news.laohu8.com/highlight/detail?id=2385645643","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2385645643?lang=zh_cn&edition=full","pubTime":"2023-11-23 15:37","pubTimestamp":1700725021,"startTime":"0","endTime":"0","summary":"11月23日,三大指数震荡走高,截至收盘,沪指涨0.6%,深成指涨0.78%,创业板涨0.58%,科创50指数涨0.81%,北证50指数冲高回落跌2.78%。两市超4100只个股上涨。沪深两市今日成交额8242亿元。北向资金全天净买入50.58亿元,其中沪股通净买入19.29亿元,深股通净买入31.29亿元。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202311_1/cb25f68c-b5ad-494a-80a2-6bb9ee5417e4.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202311_1/cb25f68c-b5ad-494a-80a2-6bb9ee5417e4.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/655f011dbde0b375aabeaed8","is_publish_highlight":false,"gpt_icon":0},{"id":"2385653569","title":"以岭药业(002603.SZ):连花清咳片处方药转换为非处方药获得批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2385653569","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2385653569?lang=zh_cn&edition=full","pubTime":"2023-11-22 18:56","pubTimestamp":1700650560,"startTime":"0","endTime":"0","summary":"以岭药业发布公告,近日,公司获悉,根据《处方药与非处方药分类管理办法(试行)》的规定,经国家药品监督管理局组织审核和论证,公司专利中药连花清咳片由处方药转换为非处方药。据悉,公司连花清咳片是首创运用中医络病理论探讨气管-支气管炎发病机制,开辟了应用络病理论指导急性气管-支气管炎防治的有效新途径。公司拥有该药独立完整的知识产权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-22/doc-imzvnvcn7257862.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-22/doc-imzvnvcn7257862.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2385500055","title":"中医药研究首登医学顶刊!以岭药业增长潜力凸显","url":"https://stock-news.laohu8.com/highlight/detail?id=2385500055","media":"新浪证券","top":-1,"share":"https://www.laohu8.com/m/news/2385500055?lang=zh_cn&edition=full","pubTime":"2023-11-22 10:19","pubTimestamp":1700619540,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 11月16日,“国家重点研发计划‘脉络学说营卫理论指导系统干预心血管事件链研究’成果发布会”在北京国家会议中心举办,会上发布了“中国通心络治疗急性心肌梗死的临床疗效——CTS-AMI随机临床研究”项目成果。 目前,该项研究论文已发表在全球医学期刊《美国医学会杂志》,2022年影响因子 120.7。这也是中成药历史首次登上国际顶级期刊。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/med/2023-11-22/doc-imzvnefz0393149.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/med/2023-11-22/doc-imzvnefz0393149.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-07-28","address":"河北省石家庄市裕华区高新技术产业开发区天山大街238号","stockEarnings":[{"period":"1week","weight":-0.0279},{"period":"1month","weight":-0.0664},{"period":"3month","weight":-0.0437},{"period":"6month","weight":-0.137},{"period":"1year","weight":-0.3894},{"period":"ytd","weight":-0.1838}],"companyName":"石家庄以岭药业股份有限公司","boardCode":"AI0027","perCapita":"7027股","boardName":"医药制造业","registeredCapital":"167070万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 石家庄以岭药业股份有限公司是一家主要致力于专利创新中药的研发、生产和销售。公司拥有通过GMP认证的胶囊、片剂、颗粒剂、针剂生产线,以及通过欧盟认证的化学药制剂车间。","serverTime":1714919843960,"listedPrice":34.56,"stockholders":"195905人(较上一季度减少8.55%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"以岭药业(002603)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供以岭药业(002603)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"以岭药业,002603,以岭药业股票,以岭药业股票老虎,以岭药业股票老虎国际,以岭药业行情,以岭药业股票行情,以岭药业股价,以岭药业股市,以岭药业股票价格,以岭药业股票交易,以岭药业股票购买,以岭药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"以岭药业(002603)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供以岭药业(002603)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}